iOncologi, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of intractable solid tumors.
Subscribe to see iOncologi, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
iOncologi, Inc. is a biotechnology company headquartered in Gainesville, United States. It has raised at least $3.3M across the 2 funding rounds on record. Its most recent funding round raised $250,000 in May 2025. Xcout tracks 18 named people at iOncologi, Inc., including Dr. Edgardo Rodriguez-Lebron (president & ceo).
As of 16 November 2026. Source: Xcout Intel.
12 more named people on record for iOncologi, Inc., with roles, board committees and tenure — see the full roster →
At least $3.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $250,000 | — | |
| Debt | $3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of iOncologi, Inc.'s closest competitors — see the full list of competitors and alternatives →
Oncolix, Inc. is an emerging clinical-stage biopharmaceutical company headquartered in Houston, Texas. The company focuses on the development of novel cancer therapeutics.
Resolute Science, Inc. is a pre-clinical life science company aiming to develop a safe, effective, and novel therapeutic for the treatment of solid tumors.
Mongoose Bio, Inc. is an emerging clinical-stage biopharmaceutical company focused on biotechnology research and advanced cancer therapeutics.
OncoSynergy, Inc. is a clinical-stage, physician-founded biopharmaceutical company headquartered in Stamford, Connecticut, focused on developing innovative oncology therapies to address unmet medical needs.
Ikena Oncology, Inc. is a targeted precision oncology company headquartered in Boston, Massachusetts, United States, focused on developing breakthrough therapeutics.
Istari Oncology, Inc. is a privately held, clinical-stage biotechnology company headquartered in Research Triangle Park (Durham), North Carolina, focused on innovative cancer immunotherapies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about iOncologi, Inc.? Suggest a correction · Work at iOncologi, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.